| abstract |
The invention relates to the use of theobromine and / or its salts and / or its complexes, optionally in admixture with other known active ingredients, and inert, solid or liquid carriers, additives and auxiliary agents for the manufacture of a pharmaceutical composition suitable for reducing cough syndrome. In addition, the subject of the invention is a method of treating people or animals in a condition in which it is desirable to alleviate cough syndrome, including the use of an effective amount of theobromine, and / or its salts, and / or its complexes, if necessary, in a mixture with other known active components and suitable inert, solid or liquid carriers, additives and auxiliary agents. |